Autor: |
Leland Metheny, Molly Gallogly, Kirsten M Boughan, Benjamin Tomlinson, Shufen Cao, Pingfu Fu, Jiasheng Wang, Ehsan Malek, Marcos de Lima, Paolo Caimi, Nicholas K. Schiltz, Folashade Otegbeye, Brenda W. Cooper, Brett Glotzbecker |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Leukemialymphoma. 62(6) |
ISSN: |
1029-2403 |
Popis: |
The role of filgrastim during acute myeloid leukemia (AML) induction therapy remains controversial. At our institution, newly diagnosed AML patients from 2003 through 2019 were retrospectively evaluated. Patients were stratified on whether they received filgrastim within 5 days after early assessment bone marrow (BMBx) and divided into early GCSF group (eGCSF) and no-eGCSF group. A total of 121 patients were included. We found significantly shorter hospital stay (median 24 vs 26 days |
Databáze: |
OpenAIRE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|